32 related articles for article (PubMed ID: 31152694)
1. Value Analysis of Four-Dimensional Color Ultrasound Combined with Maternal Serological Index in Prenatal Screening for Fetal Anomalies.
Lu H; Huang Z; Lin L; Ding X
Altern Ther Health Med; 2024 Jan; 30(1):248-253. PubMed ID: 37773685
[TBL] [Abstract][Full Text] [Related]
2. Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.
Jiang H; Lin Y; He X
Heart Surg Forum; 2023 Oct; 26(5):E552-E559. PubMed ID: 37920073
[TBL] [Abstract][Full Text] [Related]
3. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
4. The impact of fresh versus frozen-thawed embryos on maternal serum analyte levels in IVF singleton and twin pregnancies.
Peyser A; Gulersen M; Krantz D; Li X; Bornstein E; Rochelson B; Mullin C; Goldman R
J Assist Reprod Genet; 2024 Feb; 41(2):473-481. PubMed ID: 38133878
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of Serum miR-124 and miR-200C Combined with Ultrasound NT in Screening Down Syndrome in Elderly Puerperae in the Second Trimester.
Liu L; Sun Y; Xu P; Wang Y
Altern Ther Health Med; 2023 Oct; 29(7):394-399. PubMed ID: 37535911
[TBL] [Abstract][Full Text] [Related]
6. Adverse Pregnancy Outcomes by Degree of Maternal Serum Analyte Elevation: A Retrospective Cohort Study.
Yeaton-Massey A; Baer RJ; Rand L; Jelliffe-Pawlowski LL; Lyell DJ
AJP Rep; 2020 Oct; 10(4):e369-e379. PubMed ID: 33240563
[No Abstract] [Full Text] [Related]
7. Correlation between maternal serum biomarkers and the risk of fetal chromosome copy number variants: a single-center retrospective study.
Zhang M; Gao Y; Liang M; Wang Y; Guo L; Wu D; Xiao H; Lin L; Wang H; Liao S
Arch Gynecol Obstet; 2024 May; ():. PubMed ID: 38814455
[TBL] [Abstract][Full Text] [Related]
8. Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?
Tayyar AT; Tayyar A; Atakul T; Yayla CA; Kilicci C; Eser A; Karakus R; Herkiloglu D; Cundubey CR; Tayyar M
Arch Med Sci; 2018 Jun; 14(4):846-850. PubMed ID: 30002703
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Free β-hCG Multiple of the Median for Women with Preeclampsia.
Liu HQ; Wang YH; Wang LL; Hao M
Gynecol Obstet Invest; 2015 Aug; ():. PubMed ID: 26337242
[TBL] [Abstract][Full Text] [Related]
10. Association of serum beta hCG levels in women with palpable malignant breast lesions.
Mohammed A; Ahmed T; Bhat RR; Mallik E; Arulprakasam A
Sci Rep; 2023 Aug; 13(1):13208. PubMed ID: 37580469
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathways in placental-fetal development and disruption.
Adibi JJ; Zhao Y; Koistinen H; Mitchell RT; Barrett ES; Miller R; O'Connor TG; Xun X; Liang HW; Birru R; Smith M; Moog NK
Mol Cell Endocrinol; 2024 Feb; 581():112075. PubMed ID: 37852527
[TBL] [Abstract][Full Text] [Related]
12. Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.
Ma C; Jin Y; Wang Y; Xu H; Zhang J
Front Oncol; 2023; 13():1231420. PubMed ID: 37781207
[TBL] [Abstract][Full Text] [Related]
13. A toolkit for the application of placental-fetal molecular biomarkers in epidemiologic studies of the fetal origins of chronic disease.
Adibi JJ; Layden AJ; Yin Q; Xun X; Peddada S; Birru RL
Curr Epidemiol Rep; 2021 Mar; 8(1):20-31. PubMed ID: 33777648
[TBL] [Abstract][Full Text] [Related]
14. A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy.
Chen Y; Xie Z; Wang X; Xiao Q; Lu X; Lu S; Shi Y; Lv S
EPMA J; 2020 Sep; 11(3):343-353. PubMed ID: 32849925
[TBL] [Abstract][Full Text] [Related]
15. A risk prediction model for fetal hypospadias by testing maternal serum AFP and free beta-HCG.
Chen Y; Huang J; Mei J
Clin Biochem; 2019 Jul; 69():21-25. PubMed ID: 31152694
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
[TBL] [Abstract][Full Text] [Related]
17. Maternal first trimester serum levels of free-beta human chorionic gonadotrophin and male genital anomalies.
Schneuer FJ; Bower C; Holland AJ; Tasevski V; Jamieson SE; Barker A; Lee L; Majzoub JA; Nassar N
Hum Reprod; 2016 Aug; 31(8):1895-903. PubMed ID: 27496947
[TBL] [Abstract][Full Text] [Related]
18. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
Alvarez-Nava F; Soto M; Lanes R; Pons H; Morales-Machin A; Bracho A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1891-8. PubMed ID: 26369382
[TBL] [Abstract][Full Text] [Related]
19. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
